$917 Million is the total value of Fairmount Funds Management LLC's 15 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARGX | Exit | ARGENX SEsponsored adr | $0 | – | -112,903 | -100.0% | -4.54% | – |
| Exit | RAYZEBIO INC | $0 | – | -1,245,929 | -100.0% | -8.18% | – | |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -5,929,592 | -100.0% | -18.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AXSOME THERAPEUTICS INC | 18 | Q2 2024 | 24.6% |
| ARGENX SE | 17 | Q4 2023 | 9.3% |
| COGENT BIOSCIENCES INC | 15 | Q2 2024 | 7.2% |
| VIRIDIAN THERAPEUTICS INC | 14 | Q2 2024 | 6.3% |
| INSMED INC | 12 | Q3 2022 | 15.0% |
| NUVALENT INC | 12 | Q2 2024 | 17.1% |
| ACADIA PHARMACEUTICALS INC | 12 | Q3 2022 | 15.5% |
| IOVANCE BIOTHERAPEUTICS INC | 12 | Q3 2022 | 9.4% |
| ENANTA PHARMACEUTICALS INC | 12 | Q3 2022 | 9.6% |
| ALLAKOS INC | 12 | Q3 2022 | 7.4% |
View Fairmount Funds Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cogent Biosciences, Inc. | June 13, 2024 | 11,330,141 | 9.9% |
| Spyre Therapeutics, Inc. | April 25, 2024 | 4,024,541 | 10.0% |
| Apogee Therapeutics, Inc. | April 01, 2024 | 4,762,558 | 10.0% |
| Dianthus Therapeutics, Inc. /DE/ | April 01, 2024 | 2,950,487 | 10.0% |
| Viridian Therapeutics, Inc.\DE | April 01, 2024 | 13,956,685 | 18.6% |
| Annexon, Inc. | February 14, 2024 | 322,893 | 0.4% |
| Astria Therapeutics, Inc. | February 14, 2024 | 3,633,965 | 9.9% |
| Axsome Therapeutics, Inc. | February 14, 2024 | 2,360,077 | 4.9% |
| Enliven Therapeutics, Inc. | February 14, 2024 | 2,131,369 | 5.2% |
| Kiniksa Pharmaceuticals, Ltd. | February 14, 2024 | 2,883,221 | 8.1% |
View Fairmount Funds Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4/A | 2024-09-17 |
| 4 | 2024-09-17 |
| SC 13D/A | 2024-09-17 |
| 4 | 2024-09-16 |
| 4 | 2024-09-13 |
| SC 13D/A | 2024-09-13 |
| 3 | 2024-09-12 |
| 3 | 2024-09-06 |
| SC 13D | 2024-09-06 |
| N-PX | 2024-09-03 |
View Fairmount Funds Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.